MONDAY 4TH JULY – Pre-Conference Sessions
09:30 Registration and coffee
09:50 Introduction
Morning Session Chair: Dr Iqra Ashraf
10:00 Skin Surgery: Dr Vishal Madan
10:30 BSDS Quiz: Dr Aaron Wernham
10:45 Workshops :
Cryotherapy
Electrosugery
Punch Biopsy
ePosters
12:55 Lunch
Afternoon Session chair: Prof Richard Warren
13:30 DermSoc: TBC
13:45 Acute Dermatology: Dr George Kravvas
14:15 Skin of Colour Dr Mary Sommerlad
14:45 Paediatric Dermatology Dr Gabriella Petrof
15:15 Break
15:45 A taste of dermatology/ getting into dermatology Dr Luke Brindley
16:05 Social media in dermatology Dr Zena Willsmore
16:50 Careers panel – Chair: Prof Richard Warren
Dr Bernard Ho
Dr Zena Willsmore
Dr Anusha P Panthagani
Dr Luke Brindley
17:50 Closing remarks and prizes
17:55 Close Meeting
18:00 – 21:00 DermSchool, Evening social event @ SEC
12.55-13.00 Welcome
13.00-13.30 Evidence-based skin surgery/ Top Tips & Pearls for Derm surgery e.g surgery at difficult sites
13.30 -14.00 Skin oncology – immunotherapy, targeted therapy and radiology
14.00 – 14.30 Pigmentary disorders & management
14.30 – 14.45 BREAK
14.45 -15.00 How to make a good brew from BADBIR
15.00 – 15.30 Dermoscopy in the diagnosis of inflammatory dermatoses
15.30 -16.00 Common Nail disorders and treatment
16.00- 16.30 Teledermatology
16.30-16.45 BREAK
16.45 – 17.15 Lasers/ Cosmetic dermatology
17.15 – 17.55 Post-CCT Fellowship Careers panel – Mohs surgery – paeds – cutaneous allergy – medical hair& nail – (5 min overview of each area and Q&A)
Chairperson (TBC)
17.55-18.00 CLOSE
12:55 – 13:00 Dr Fareeha Faisal Welcome
13:00 – 13:30 Speaker TBC Paediatric Dermatology Emergencies Survival Guide
13:30 – 14:00 Dr Aarthi Mohan I’m a Dermatologist……..Get me out of the Labour Ward (or what a Dermatologist needs to know about looking after Pregnant Women’
14:00 – 14:30 Dr Robert Sarkany Making Sense of Porphyria
14:30 – Break
14:45 – 15:00 Dr Amaya Viros Skin oncology – immunotherapy, targeted therapy, and radiology
15:00 – 15:30 Dr Ljubomir B Novakovic Phototherapy – Basic science
15:30 – 16:00 Dr Susan Howell Dermatophytes
16:00 – 16:30 Dr Barbara Carey Oral Immunobullous
16:30 – Break
16:45 – 17:15 Dr Fareeha Faisal Executive Leadership and Coaching in NHS
17:15 – 17:55 SAS Committee – Open Q&A – Career talk
17:55 – 18:00 Close
The BSD Self Assessment session will be a virtual only session
Announcing the British Society for Dermatopathology’s
9th Annual Dermatopathology Self-Assessment
Virtual Course 2022
EXAMS SPECIAL!
• After the success of last year’s virtual BSD self-assessment course, this year’s course will again be fully online.
• 40 self-assessment dermatopathology cases with MCQs available to view online before July. Link to follow.
• This year is an exam special! Half of the 40 cases will be examples of cases suitable for the FRCPath or Dermatology SCE examinations. Half of the 40 cases will be examples of cases suitable for the RCPath Diploma in Dermatopathology or American Board Examinations.
• For registered participants, there will be detailed video presentations of all of the cases with answers and differential diagnoses from our speakers available online from July 4 2022 and the videos will remain available online throughout July.
• Registration fees: BSD or BAD members £70. Trainees £40. Non members £100. Please note that BSD membership is £15 per year.
• To join the BSD please follow this link: https://www.bad.org.uk/healthcare-professionals/specialist-groups/british-society-for-dermatopathology
• The course is aimed at dermatopathologists, histopathologists, dermatologists and trainees.
• For registered participants, 7 RCPath CPD points approved for.
The BSD 2022 Self-assessment speakers:
Dr Ahmed Basiouni (Royal United Hospitals Bath)
Dr Asok Biswas (Western General Hospital, Edinburgh)
Dr Eduardo Calonje (St.John’s Institute of Dermatology, London)
Dr Paul Craig (Cheltenham Hospitals)
Dr Ruth Green (Salford Royal NHS Foundation Trust)
Dr Eleni Ieremia (Oxford University Hospitals)
Dr Nitin Khirwadkar (Royal Liverpool University Hospitals)
Dr Bipin Mathew (St. James’s University Hospital, Leeds)
Dr Tor Swale (Royal Free Hospital, London)
Dr Nick Tiffin (St. George’s University Hospital, London)
PROGRAMME SURVIVAL GUIDE FOR CONSULTANTS MONDAY 4 JULY 2022
Chairs Dr Piu Banerjee and Prof Tony Bewley
12.55pm Welcome – Dr Piu Banerjee
1pm Burnout and Resilience – Prof Anthony Bewley
1.20pm Press the Pause Button – Dr Emma Went
1.40pm Mindfulness Demystified – Dr Shaun Bhattarcherjee
2pm ‘overview of human factors application for us as clinicians and discuss optimising individual and team performance’ – Prof Peter Brennan
2.30pm Inspirational Speaker – Dr Chaand Nagpaul
COFFEE 3pm-3.20pm
WORKSHOPS
CHAIRS Dr Piu Banerjee and Dr Nuala O’Donoghue
3.20pm Push button Questions – Dr Nuala O’Donoghue, Dr Piu Banerjee, Dr Justine Hextall and Prof Tony Bewley
3:30pm- Breakout tables – ‘Sharing service issues’ – moderated by BAD officers
4.15pm Microaggressions and Allyship – Cheryl Carty
4:45pm Experiential session of Mindfulness -Dr Shaun Bhattarcherjee
5.15pm Movement as Medicine – Gee Gahir
5.45pm Close of meeting – Dr Piu Banerjee
TUESDAY 5TH JULY
PROGRAMME | ||
08:45 – 08:52 | CPC01 | Clinically distinct attributes of histologically confirmed keratoacanthoma and cutaneous squamous cell carcinomas Volha Shpadaruk, Domenico Mesiano, James Wiggins, Simon Tso, David Slater, Paul Craig and Richard A. Carr |
08:52 – 08:59 | CPC02 | An unusual case of rash secondary to the COVID-19 vaccine is presented with a review of the literature Perin Celebi, Alex Gan, Rand Hawari and Tanya Bleiker |
08:59 – 09:06 | CPC03 | Generalized essential telangiectasia response to treatment with oral dabigatran: a case report Elian Karim, Anna Ascott, Christine Aziz and Arjida Woollons |
09:06 – 09:13 | CPC04 | Immune checkpoint inhibitor therapy and psoriasis: a case series Khawar Hussain, Alpa Kanji, Shirin Zaheri, Monica Terlizzo, Justin Weir and Louise Fearfield |
09:13 – 09:20 | CPC05 | Plasma cell mucositis: a complex and challenging condition Majella Gregory, Anisah Soobraty, Paul Yesudian and Anne Field |
09:20 – 09:27 | CPC06 | Cutaneous metastases from triple-negative lobular breast cancer in the contralateral breast in a zosteriform pattern Lisa O’Higgins, Marina O’Kane and Christian Gulmann |
09:27 – 09:34 | CPC07 | Erythromelalgia associated with small-fibre neuropathy Livia Francine Soriano, Sophie Stoneham and Helen Lotery |
09:34 – 09:41 | CPC08 | New-onset pemphigus foliaceus following COVID-19 vaccine Mina Almasi-Nasrabadi, R. Sowjanya Ayyalaraju, Ashish Sharma, Somaia Elsheikh and Shanti Ayob |
09:41 – 09:48 | CPC09 | A contrasting diagnosis: iododerma Aine Kelly, Ratnam Gandhi, Nisha Arujuna and Jana Natkunarajah |
09:48 – 09:55 | CPC10 | First reported case of parvovirus triggering painful widespread livedoid vasculopathy: another virus causing hypercoagulability? Alison Lawton and James Powell |
09:55 – 10:02 | CPC11 | Bromoderma in a patient with chronic obstructive pulmonary disease Xavier Peer, Ahmed Zwain, Marina Subnikova and Saleem Taibjee |
10:02 – 10:09 | CPC12 | Alopecia due to chronic graft-versus-host disease Rachel Pierce, Stephen Walker and Faris Kubba |
10:09 – 10:16 | CPC13 | Comparative study of p16, p53 and Ki67 immunostaining indicates that keratoacanthoma and cutaneous squamous cell carcinoma are clinicopathologically distinct entities Volha Shpadaruk, Richard A. Carr, Domenico Mesiano, Cinthia Heffron, Teodora Radonic, James Wiggings, Simon Tso, Rishi Agrawal, Elaine Cheung, David Slater and Paul Craig |
10:16 – 10:23 | CPC14 | A rare adult presentation of cutaneous Langerhans cell histiocytosis associated with acute transformation of myeloid leukaemia Ahmed Zwain, Xavier Peer, Saleem Taibjee and Dimitra Koch |
15:00 – 15:10 Lord Provost Welcome Civic speech by the Rt Hon The Lord Provost of Glasgow or representative’
15:10 – 15:30 Inv01 Prof Jomo Sundaram (Malaysia) – Economic challenges with sustainable development and poverty
15:30 – 15:50 Inv02 Dr Tess McPherson , Suzi Holland and the EOS Youth Panel – Eczema Outreach Support Patient
15:50 – 16:10 Inv03 Prof Colin Fleming – The AI skin cancer consortium: Stepping stones to AI in UK dermatology
16:10 – 16:40 KL01 Prof Sir Michael Marmot – Social Justice and Health Equity
16:40 – 17:10 KL02 Prof Partha Kar – MWRES (Medical Workforce Race Equality Standards): The data speaks- what next?
17:30 – 18:30 BAD AGM (Members Only)
Tuesday 5th July
Time: 11:00-15:15
Room: Lomond
Chair: Dr Saleem Taibjee
PROGRAMME
11:00 DP01 Getting the whole picture on melanoma diagnosis: investigating the effects of clinical images and dermoscopy report on the histopathology diagnosis of melanocytic skin lesions
Belinda Lai, Blake O’Brien, Tristan Dodds, Peter Ferguson, Richard Scolyer, Gerardo Ferrara, Giuseppe Argenziano, H. Peter Soyer and Katy Bell
11:05 Joint BAD/BSD Neil Smith Lecture
Introduced by: Dr Mark Bamford and Dr Luisa Motta
Clinicopathological correlation in dermatopathology
Dr Eduardo Calonje
11:50 DP02 AMBLor: an immunohistochemical prognostic biomarker to identify low-risk nonulcerated cutaneous AJCC stage I/II melanomas
Philip Sloan, Tom Ewen, Gyorgy Paragh, Paul Bogner, Akhtar Hussain, Niki Stefanos, Paul Barrett, Sonia Mailer, Grant McArthur, Jane Meaney, Richard Tuson and Penny Lovat
11:59 DP03 Alopecia areata-like histopathology in lupus: follicular and stromal clues to diagnosis
Nikolina Lalagianni, David A. Fenton, Anoud Zidan and Catherine M. Stefanato
12:08 DP04 An elderly man with a relapsing and remitting neutrophilic dermatosis and final unifying diagnosis of VEXAS syndrome
Khimara Naidoo, Sowmya Venkatesan, Andrew McGregor and Saman Fatah
12:17 Lunch Exhibition Hall
13:15 DP05 A tough row to hoe: treating a novel recalcitrant facial rash
Wajeeha Khan, Naomi Carson, Aparna Sinha and Natalie Stone
13:24 DP06 Clinical and histopathological correlation of the mucocutaneous COVID-19 vaccine reactions: a prospective observational study
Alpana Mohta
13:30 DP07 Granulomatous polyangiitis masquerading as pyoderma gangrenosum, acne and hidradenitis suppurativa (PASH) syndrome
Kiran Kaur Gurdial Singh, Florence Garty, Ahmed Basiouni and Naila Dinani
13:36 DP08 Metastatic cutaneous myoepithelial carcinoma: a case report
Sarah McCusker, Alastair Milne, Steven Lo and Amrita Randhawa
13:42 DP09 A case of cutaneous collagenous vasculopathy with concomitant gastric antral vascular ectasia
Stephanie Bowe, Anna Wolinska, Gregg Murray, Cliona Feighery and Jane Thorne
13:48 DP10 A case of reactive angioendotheliomatosis with resolution following improved glycaemic control
Florence Garty, Kiran Kaur Gurdial Singh, Ahmed Basiouni, Sarah Rasool and Sarah Woodrow
14:00 Guest speaker:
Miscellaneous observations in dermatopathology
Dr Eduardo Calonje
Date: Tuesday 5th July
Time: 08:30-12:15
Room: Alsh 1 & 2
Chairs: tbc
PROGRAMME
08:30 Welcome & Introduction
08:55 BI01 Dupilumab in the management of atopic dermatitis in an immunosuppressed renal transplant patient
Shahd Elamin and Bryan Murphy
09:00 BI02 (P97) Epidermal growth factor receptor inhibitor therapy induces a distinct inflammatory hair follicle response that includes a collapse of immune privilege
David Rutkowski, Richard Warren, Christropher Griffiths and Ralf Paus
09:07 BI03 Renal transplant patients and photoprotecting: do they practice what we preach?
Olga Tummon, Aoife Hollywood, Maria Stanciu and Lyndsey Paul
09:12 BI04 Short sharp shock or slow burn: immunocompromised patient perspectives on treatment of actinic keratoses with 5-fluorouracil 5% cream monotherapy versus 5-fluorouracil/calcipotriol ointment combination therapy
Muhammad Hyder Junejo, Sibel Demirel, Rubeta N. Matin, Charlotte Proby and Catherine Harwood
09:19 DISCUSSION TIME
09:24 BI05 Is a hybrid skin cancer surveillance service for organ transplant recipients feasible? Lessons from the pandemic
Jaimie Oldham, Pia Tookey, Rebecca Morgan, Sharumilan Ravindran, Zeeshaan Hasan, Rebeca Goiriz and Catherine Harwood
09:31 BI06 Rates of perineural invasion in cutaneous squamous cell carcinoma in an Irish cohort of renal transplant recipients versus immunocompetent patients
Claire Doyle, Kira Casey and Siona Ni Raghallaigh
09:38 BI07 Squamous cell carcinoma arising in oral graft-versus-host disease: a case series
Catherine Drislane, Fiona Child and Helen McParland
09:43 BI08 Use of cemiplimab for advanced cutaneous squamous cell carcinoma: first real-world data from a UK perspective – a retrospective review
Laura Aisling Nestor, M.J. Payne, Nicholas Coupe, Ben Fairfax, A.J. Salisbury and R.N. Matin
09:50 DISCUSSION TIME
09.55 BIGL Guest Lecture: Title TBC
Professor Marc Lipman
10:30 Break Exhibition Hall
11:00 BI09 Rapid and progressive papular facial and truncal rash due to trichodysplasia spinulosa-associated polyomavirus: a diagnosis to consider in immunosuppressed patients
Zahra Moledina, Esther Burden-Teh, Kusum Kulkarni and Shanti Ayob
11:05 BI10 Skin warts during fingolimod treatment for multiple sclerosis: a UK cross-sectional study
Yasmin Khan, Pamela Todd and Claire McCarthy
11:10 BI11 Cutaneous Parathyridaria percutanea in a renal transplant patient
Arzo Rafiq, Ferina Ismail, Mark Harber, Sophie Collier and Timothy Churchill
11:15 BI12 A retrospective analysis of cases of Kaposi sarcoma in patients at a tertiary centre
Dalvir Bajwa, Pooja Jassal-Prior and Dominic Tabor
11:20 DISCUSSION TIME
11:25 BI13 WITHDRAWN
11:30 BI14 Painful cutaneous nodules in chronic neutrophilic leukaemia
Christopher Phillips, Olivia Espinosa, Gorav Wali, John Reed and Rubeta Matin
11:35 BI15 The impact of COVID-19 and ruxolitinib on extracorporeal photopheresis in chronic graft-versus-host disease: a retrospective observational study
Libin Mathew, Sukran Saglam and Fiona Child
11:40 BI16 Severe epidermolysis bullosa acquisita in a patient with graft-versus-host disease: causal or coincidental?
Jaimie Oldham, Sasha Dhoat, Catherine Harwood and Rebeca Goiriz
11.45 DISCUSSION TIME
11:50 AGM
All BSSCII members most welcome and invited to contribute
Date: Tuesday 5th JulyTime: 08:30-12:10
Room: Boisdale 1 & 2
Chair: Natalie Stone and Graham Johnson
Sarah Wakelin and John McFadden
PROGRAMME
08:30 AGM
09:00 CD01 The ‘extended’ facial series audit: recommendation to include shellac and sodium benzoate in the British Society of Cutaneous Allergy Facial Series
Sophie Rolls, Deirdre Buckley, Mahubub M.U. Chowdhury, Simon Dawe, Catherine Holden, Faheem Latheef, Avad Mughal, Birgit Pees, Asha Rajeev, Ruth Sabroe, Livia F. Sorano, Donna Thompson, Heather Whitehouse, Mark Wilkinson and Natalie Stone
09:10 CD02 Is it time to patch test methylisothiazolinone (MI) and methylchloroisothiazolinone/MI mix in petrolatum? A concerning recent rise in sensitization also revealed
Catherine Holden and Ruth Sabroe
09:20 CD03 Practical use of a limonene and linalool series
Siobhán McCarthy, Felicity Ferguson, Louise Cunningham, Ian White and John McFadden
09:30 CD04 Linalool allergy presenting as lip swelling and tongue ulceration
Dushyanth Gnanappiragasam, Graham Johnston and Ingrid Helbling
09:40 CD05 Retrospective analysis of patch testing in patients with leg ulcer
Dushyanth Gnanappiragasam and Graham Johnston
09:50 CD06 ‘Bees wax wraps’: a novel source of colophony allergic contact dermatitis
Natalie Stone, Iman Hamid and Lokapriya Ananthan
10:00 CD07 Contact allergy to Efudix cream: a reminder and review
Vidya Madhwapathi and D.A. Thompson
10:10 CD08 Barriers to improvement: the role of tackifying agents in persisting continuous glucose monitoring-associated allergic contact dermatitis
Lauren Passby and Donna Thompson
10:20 CD09 Palmoplantar inflammation with a broad differential diagnosis made clear upon patch testing
Orla McFeely, Emily Pender, Liana Victory and Eoin Storan
10:30 Break Exhibition Hall
11:00 Prosser White Oration ‘Vaccine Allergy’
Dr Chris Rutkowski
11:20 CD10 Occupational and work-related contact dermatitis attributed to nickel, chromium and cobalt in the UK: findings from The Health and Occupational Research network 1996–2019
Ireny Y.K. Iskandar, David J. Gawkrodger, Matthew Gittins, Martin J. Seed, Melanie Carder and Martie van Tongeren
11:30 CD11 Irritant hand dermatitis to alcohol gel in healthcare workers: consideration of inherent genetic polymorphism
Ying Teo, Roberto Corso, Louise Cunningham, Christos Tziotzios, Ian White and John McFadden
11:40 Guest Lecture Formulating cosmetics why do we need preservatives?
Dr Robin Parker
M1 Room
SESSION 1:
09:00 – 09:50 Scientific Session – Abstracts
09:50 – 10:20 Guest Lecture – “BSDS Anticoagulation Survey and Guideline Update” – Dr Aaron Wernham & Dr Adam Bray
10:20-11:00 Break
SESSION 2:
11:00-11:40 Scientific Session – Abstracts
11:40 – 12:05 Rapid Fire Reconstruction Round
12:10-13:15 Lunch
SESSION 3:
13:15 – 14:00 Focus Session – Dr Lisa Naysmith “Tiger Territory and Surgical Litigation”
14:00 – 14:30 Dr Wal Hussain – “Mohs EQA”
16:15 – 17:00 BSDS AGM
Chairs: Piu Banerjee and Bisola Laguda
13:05 Prof Amali Lokugange – ’What is cultural safety and how could it improve healthcare in UK?”
13:25 Prof Nina Jablonski – ’Evolution of Skin pigmentation’
13:45 EASI scoring in skin of colour
13:50 Skin cancers in skin of colour survey: current unmet needs
13:55 BAD and Diversity – Questions and Answers’ with Skin Diversity Subcommittee and BAD Education Board moderated by Piu Banerjee, Tanya Bleiker and Tamara Griffiths
Guest Speaker
Prof Richard Fuller
The rise of the machine? Data, devices and decision making in portfolio assessment
WEDNESDAY 6TH JULY
PROGRAMME | ||
08:45 – 09:00 | O01 | Vitiligo diagnosis is associated with an increase in new-onset depression and anxiety: a population-based cohort study in the UK Viktoria Eleftheriadou, Andrew Thompson and John Nesnas |
09:00 – 09:15 | O02 | Risk of severe COVID-19 outcomes associated with immune-mediated inflammatory diseases and immune-modifying therapies: a nationwide cohort study in the OpenSAFELY platform Sinéad Langan, Brian McKenna, Nicholas Kennedy, Amir Mehkar, Anna Rowan, James Galloway, Julian Matthewman, Kathryn Mansfield, Katie Bechman, Mark Yates, Jeremy Brown, Anna Schultze, Sam Norton, Alex Walker, Caroline Morton, David Harrison, Krishnan Bhaskaran, Christopher Rentsch, Elizabeth Williamson, Richard Croker, Seb Bacon, George Hickman, Tom Ward, Simon Davy, Amelia Green, Louis Fisher, William Hulme, Chris Bates, Helen Curtis, John Tazare, Rosalind Eggo, David Evans, Peter Inglesby, Jonathan Cockburn, Helen McDonald, Laurie Tomlinson, Rohini Mathur, Angel Wong, Harriet Forbes, John Parry, Frank Hester, Sam Harper, Ian Douglas, Liam Smeeth, Charlie Lees, Stephen Evans, Ben Goldacre and Catherine Smith |
09:15 – 09:35 | MD01 | Prof M Ramam Novel cutaneous clues to systemic diseases |
09:35 – 09:50 | O03 | Effect modification of biologic survival by patient characteristics: a prospective cohort study from the British Association of Dermatologists Biologics and Immunomodulators Register Zenas Yiu, Gabrielle Becher, Brian Kirby, Philip Laws, Nick Reynolds, Catherine Smith, Mark Lunt, Richard Warren and Christopher Griffiths |
09:50 – 10:10 | MD02 | Dr Ruth Lamb – Surgical management of Hidradenitis Suppurativa |
10:10 – 11:00 | Break | |
11:00 – 11:15 | O04 | Efficacy and safety of dupilumab in children aged ≥ 6 months to < 6 years with moderate-to-severe atopic dermatitis Amy S. Paller, Michael J. Cork, Elaine C. Siegfried, Eric L. Simpson, Andreas Wollenberg, Mercedes E. Gonzalez, Yiping Sun, John T. O’Malley and Ashish Bansal |
11:15 – 11:30 | O05 | ‘A raised P3NP is a matter of time’: replacing P3NP with FIB-4 for monitoring of methotrexate-related liver fibrosis Mina M Raahimi, Amy Livesey, Jessica Hamilton, Charles Mitchell and Alexa Shipman |
11:30 – 11:45 | O06 | A randomized controlled trial assessing the effectiveness and safety of ciclosporin vs. methotrexate in the treatment of severe atopic eczema in children and young people: the TREatment of severe Atopic eczema Trial (TREAT) Carsten Flohr, Ashley Jones, Anna Rosala-Hallas, Paula Beattie, Susannah Baron, Fiona Browne, Sara Brown, Joanna Gach, Ross Hearn, Ben Esdaile, Michael Cork, Emma Howard, Danielle Greenblatt, Marie-Louise Lovgren, Suzannah August, Farhiya Ashoor, Paula Williamson, Tess McPherson, Donal O’Kane, Jane Ravenscroft, Lindsay Shaw, Manish Sinha, Catherine Spowart, Leonie Taams, Mandy Wan, Tracey Sach and Alan Irvine |
11:45 – 12:05 | MD03 | Dr Hudaa Gopee – Lessons from the developing human skin’ |
12:05 – 12:25 | MD04 | Prof Jayakar Thomas – Hypotrichosis in Children – An approach to diagnosis and treatment |
PROGRAMME | ||
14:00 | BMJ Dermatology Team of the Year | |
14:15 | O07 | Carbonylated proteins as markers of oxidative stress and their association with filaggrin genotype in atopic eczema Soha Tawfik, Krishanu Baruah, Aaron Hughes, Bjorn Thomas, Ryan O-Shaughnessy and Edel O’ Toole |
14:30 | O08 | Skin tumours in England 2013–19: in-depth reporting of a new consensus classification to improve prospective data extraction and clinical interpretation Birgitta van Bodegraven, Sally Vernon, Charlotte Eversfield, Ruth Board, Paul Craig, Sonia Gran, Catherine Harwood, Stephen Keohana, Nick Levell, Rubeta N. Matin, Charlotte Proby, Neil Rajan, Brian Rous and Zoe Venables |
14:45 | O09 | A national review of porocarcinoma epidemiology in England 2013–2018 Jilse Joshy, Birgitta van Bodegraven, Paul Craig, Nick J. Levell, Khaylen Mistry, Neil Rajan, Sally Vernon and Zoe C. Venables |
15:00 | O10 | National Merkel cell carcinoma epidemiology and mortality-related risk factors in England 2004–2018 Khaylen Mistry, Nicholas Levell, Paul Craig, Craig Knott, Loes Hollestein, Tamar Nijsten, Neil Steven, Marlies Wakkee and Zoe Venables |
16:00 – 16:30 KL03 Prof Marc Lipman – Pre-biologic assessments for infection: what do we need to know?
16:30 – 16:50 Inv04 Prof Andrew Goddard – What I’ve learned as PRCP
16:50 – 17:20 KL04 Dr Roxana Daneshjou – AI in Dermatology: Overcoming Biases
17:20 – 17:40 Inv05 Prof Sally Ibbotson – Photosensitivity and Photodiagnosis
Date: Wednesday 6th July
Time: 09:00-12:30
Room: Alsh 1 & 2
Chair: Edel O’Toole & Neil Rajan
PROGRAMME
09:00 BG01 Safety and efficacy of oleogel-S10 (birch triterpenes) for epidermolysis bullosa: results of a 12-month interim analysis of the open-label phase from the EASE study
Anna Martinez, Dedee F. Murrell, Anna L. Bruckner, Johannes Kern, Laura Maher and Tracy Cunningham
09:10 BG02 (P35) Alterations of forces applied under the feet in patients with epidermolysis bullosa simplex during gait
Manrup Hunjan, Valter Devecchi, Ajoy Bardhan, Natasha Harper, Mark O’Sullivan, Deborah Falla and Adrian Heagerty
09:20 – 09:30 BG03 Epidermolysis bullosa-associated verruciform xanthomas: case series and review of the literature
Ebunoluwa Oluwole, Jemima Mellerio, John McGrath, Danielle Greenblatt, Eduardo Calonje, Anoud Zidan, Eglantine Lebas and Suzy Leech
09:30 – 10:00 BGGL1 Insight into DERMATLAS – the new genomic atlas of skin tumours.
Dr Ingrid Ferreira, Sanger Institute, Hinxton, UK
10:00 – 10:10 BGO4 Exploring the cellular and genetic composition of human basal cell carcinoma at single-cell and spatial resolutions
Clarisse Ganier, Nasrat Harun, Xinyi Du-Harpur, Fiona Watt and Magnus Lynch
10:10 – 11:00
Break
11:00 – 11:30 BGGL2 Advancing genomic literacy in dermatology
Dr Neil Rajan, Newcastle University, Newcastle-upon-Tyne, UK
11:30 – 11:40 BG05 More than skin deep: a life-changing diagnosis from the 100,000 Genomes Project
Shehryar Khan, Lucy Cliffe, Elizabeth McDermott, Mohnish Suri and Jane Ravenscroft
11:40 – 11:50 BG06 VEXAS syndrome: a case series
Mhairi Duncan, Tanya Basu, Jon Salisbury, Austin Kulasekararaj and David Sterling
11:50 – 12:00 BG07 Aberrant calcium signalling and systemic hypocalcaemia in GNAQ/11 mosaic diseases
Davide Zecchin, Nicole Knoepfel, Anne Gluck, Mark Stevenson, Satyamaanasa Polubothu, Noreen Muwanga-Nanyonjo, Sara Barberan-Martin, Fanis Michailidis, Dale Bryant, Ulrike Loebel, Hanna Richardson, Sarah Aylett, Martin Tisdall, Asuka Inoue, Robert Semple, Rajesh Thakker and Veronica Kinsler
12:00 – 12:30 BGGL3 Biologics in ichthyosis
Professor Amy Paller, Northwestern University, Chicago, USA. Virtual, live for questions and answers
Date: Wednesday 6th July
Time: 11:00-15:36
Room: Boisdale 1 & 2
Chairs:
Carolyn Charman & David de Berker
Rubeta Matin and Lucy Thomas
PROGRAMME
11:00 Welcome – overview
11.10 BT01 Results of a pilot optional e-triage teledermatology advice and guidance pathway for equivocal lesions as an alternative to 2-week wait referrals in two large general practitioner networks in a city
William Hunt, Angela Downing, Sophie Holloran, Callum Binnie, James Boorer and Toby Nelson
11:22 BT02 Teledermatology versus SPOT diagnosis clinic: what is the best option for your patients and service?
Gavin O’Sullivan, Esra Musbahi and Paul Farrant
11:34 BT03 (P47) Effects of the COVID-19 pandemic on quality of utilization of the 2-week wait skin cancer pathway
Hannah Ross, Shane Kukuswadia, Richard Azurdia and Elizabeth West
11:46 BT04 Teledermatology triage models: redesigning the concept of outpatient referral
Carolyn Charman, John Frewen and Christopher Bower
11:58 BT05 Setting up an NHS e-RS advice and guidance single-referral pathway for paediatric dermatology
Laura Adams, Perin Celebi and Tanya Bleiker
12:10 BT06 Measuring ‘time to care’ in an outpatient setting: a novel methodology
Matthew Alexander
12:22 LUNCH BREAK
14:00 BT07 Could virtual dermatology services widen healthcare inequity for patients with chronic skin conditions: are we READHY?
Aditya Umeshkumar Patel, Hanen Mohamed Thani, Rebeca Goiriz, Catherine Harwood, Richard H. Osborne, Christina Cheng and Zeeshaan-ul Hasan
14:12 BT08 (P48) Developing dermatology video consultations: a determination of quality
Eimear Gilhooley, Catriona Gallagher, Lisa Kiely and John Bourke
14:24 BT09 (P56) Inpatient teledermatology service: baseline review – it works!
James Powell, Balveer Kaur, Alison Lawton, Victoria Mackie, Victoria Diba, Samiya Rahman, Nadia Bassi, Helen Leach, Charlotte Arden and Nancy Bray
14:36 BT10 (P54) Development of a national dataset of skin images to support evidence-based artificial intelligence in dermatology
Shareen Muthiah, Sanaa Butt, Stuart McKenna, Emanuele Trucco, Rubeta Matin, Colin Fleming and Colin Morton
14:48 BT11 How to train your artificial intelligence (AI) dragon: an analysis of human triage performance of community captured images to inform development of AI solutions
Gillian X.M. Chin, Callum Hakimi-Khiabani, Sanaa Butt, Alyson Bryden, Shareen Muthiah, Tamas Suveges, Colin Morton, Andrew Coon and Colin Fleming
15:00 BT12 Key steps in the coding of an image dataset for the development of artificial intelligence in dermatology
Shareen Muthiah, Fiona Craig, Siobhan Sinclair, Sanaa Butt, Gillian Chin, Colin Fleming and Colin Morton
15:12 BT13 Prepare to succeed: real-world image datasets for artificial intelligence in skin cancer triage
Gillian X.M. Chin, Tamas Suveges, Jacob Carse, Sanaa Butt, Shareen Muthiah, Colin Morton, Emanuele Trucco, Charlotte Proby, Stephen McKenna and Colin Fleming
15:24 BT14 (P71) Accessibility and connectivity of skin cancer datasets and reporting of machine learning model performance across skin phototypes and cancer types: a systematic review
Lloyd Steele, Xiang Li Tan, Bayanne Olabi, Jing Mia Gao, Reiko Tanaka and Hywel Williams
Time: 08:55-12:30
Room: M1
Chair: Hayley Leeman and Emma Craythorne
PROGRAMME
08:55 – 09:00 Welcome
09:00 – 09:30 BCGL1 Surgical and non-surgical management of acne scarring
Dr Rakesh Patalay
09:30 – 09:40 BC01 (P99)
A split-scalp study to compare the effects of platelet-rich plasma prepared and activated by two different methods in androgenetic alopecia
Anil Budania and Saptarshi Mandal
09:40 – 10:10 BCGL2 Surgical and non-surgical management of keloid scarring
Dr Ioannis Goutos
10:10 – 10:20 BC02 A systematic review of skin resurfacing techniques used to enhance transepidermal delivery of topical biostimulants in the management of atrophic acne scarring
Rebecca Hellen and Bav Shergill
10:20 – 10:45 Break
10:45 – 11.15 BCGL3 Early interventions to optimise scarring outcome
Dr Rhonda Meys
11.15 – 11:25 BC03 Evaluation of fractional ablative CO2 laser and triple combination cream in the treatment of melasma: a randomized controlled study
Kaushal Verma, Utpal Patel, G. Sethuraman and Neetu Bhari
11.25 – 11.50 BCGL4 Early outcomes of Injectables BCDG course for dermatologists
Dr Emma Craythorne
11:50 – 12:00 Questions and Discussion
12:00 – 12:30 AGM
Time: 14:00-15:30
Room: Carron 1 & 2
Chair: Prof David Gawkrodger & Dr Paul Yesudian
PROGRAMME
14:00 – 14:30 HGL “Renaissance skin”
Dr Hannah Murphy (London)
14:30 – 14:45 H01 After the blast: a skin perspective
Natalie King Stokes
14:45 – 15:00 H02 Causes of admission and mortality to a nineteenth-century English workhouse infirmary, with a focus on dermatological conditions
Sofia Labbouz, Alice Manley and David Gawkrodger
15:00 – 15:15 H03 (P45) Chilblain: a brief history of cold comfort remedies
Amy Wai Ying Wong, Harry Edmund Gordon White and Alexa Rose Shipman
15:15 – 15:30 H04 Washing the great unwashed: a history of British public hand hygiene
Sarah Dyson, Chandni Ondhia and Nick Levell
16:30 – 16:35 Introduction and welcome –
Prof Eugene Healy, University of Southampton
16:35 – 16:55 Microneedles for topical drug delivery
Prof Ryan Donnelly, Queen’s University Belfast
16:55 – 17:15 What do cosmetic dermatologists want from skin biologists?
Dr Emma Craythorne, Guy’s and St Thomas’ NHS Foundation Trust
17:15 – 17:35 Podoconiosis – maintaining skin health
Dr Paul Matts, Proctor and Gamble
17.35 – 17.55 What help can skin biologists offer dermatologists in terms of improving skin health?
Dr Ryan O’Shaughnessy, Queen Mary University of London
17:55 – 18:00 Closing remarks –
Prof Veronica Kinsler, Francis Crick Institute
Your Content Goes Here
Date: Wednesday 6th July
Time: 14:00 – 15:30
Room: Alsh 1 & 2
Chair: Richard Weller & Claire Fuller
PROGRAMME
14:00 – 14:05 Introduction
Richard Weller
14:05 – 14:20 GDGL1 Invited Speaker: RCP’s new Global Strategy
Mumtaz Patel. RCP Vice President Global.
14:20 – 14:35 GDGL2 Invited Speaker: NTD framework
Prof Rie Yotsu
14:35 – 14:50 GDGL3 Invited Speaker: Mapping the international burden of atopic eczema – the ILDS Global Atopic Dermatitis Atlas (GADA) project
Prof Carsten Flohr
14:50 – 15:05 GDGL4 Invited Speaker: Interactions with International Health Agencies
Prof Chris Griffiths
15:05 – 15:12 GD01 (P31) Clinical and Chemokine Profile in Leprosy Patients During Multidrug Therapy (MDT) and Their Healthy Contacts: A Randomized Control Trial
Dr Rohit Kothari
15:12 – 15:19 GD02 The use of dermoscopy in diagnosis of scabies
Dr Hemn Perot
15:19 – 15:26 GD03 A skin disease survey of the Maasai in Northern Tanzania
Sidra S Khan, Darren M Ashcroft, Daudi Mavura, Rune N Philemon, Doriane Sabushmike, Rebekah Swan, Niro Trialonis-Suthakharan, Aakaash Varma, Christopher EM Griffiths
15:26 – 15:30 Final Comments
Date: Wednesday 6th July
Time: 14:00-17:00
Room: M1
Chair: Before break: Susannah Baron & Alia Ahmed
After break: Padma Mohandas & Tony Bewley
PROGRAMME
14:00 – 14:10 Welcome:
14:10-14:45 PSGL1 Guest Lecture: Somatoform disorders – how to recognise and manage
Iyas Assalman Consultant Psychiatrist
14:45 – 14:55 PS01 (P18)
Prescribing antipsychotics in dermatology: a national survey of clinical experience, physician confidence and training needs
Ling Li, Rachel Fisher, Gorav Wali and Leila Izadi Firouzabadi
14.55 -15:05 PS02 (P16) Gender and sexual identity: unmet dermatological needs of LGBTQ+ individuals and how dermatologists can provide better care: a qualitative analysis of a cross-sectional survey
Callum Phillips, Jennifer Ritehnia, Lisa Bickerstaffe and Bernard Ho
15.05 – 15.15 PS03 A case series of compulsive hair pulling (trichotillomania) in children and young people presenting at a tertiary paediatric psychodermatology clinic
Christina Tang, Rukshana Ali and Susannah Baron
15:15 – 15:45 Break Exhibition Hall
15:45 – 15:55 PS04 (P64) The national comprehensive cancer network distress thermometer as a screening tool for psychological and social distress in patients with keratinocyte skin cancer
Aoife Granahan, Olga Tummons, Aoife Maloney, Aoife Lally and Blaithin Moriarty
15:55 – 16:05 PS05 Extreme psychogenic self-mutilation: a case series
Marianne de Brito, Padma Mohandas, Iyas Assalman, Ruth Taylor, Alia Ahmed and Anthony Bewley
16:05 – 16:15 PS06 Gender and sexual identity: why dermatologists should ask about them: a quantitative analysis of a cross-sectional survey
Jennifer Ritehnia, Callum Phillips, Lisa Bickerstaffe and Bernard Ho
16:15 – 16:25 PS07 Service planning for delivery of specialized psychology support to medical dermatology: experience of a participatory co-design approach at a London teaching hospital
Saman Zaman, Shafiah Abdul-Gafoor, Navneet Singh, Ruth Lamb, Catriona Maybury and Leila Ferguson
16:25 – 16:35 PS08 A prospective noninterventional study to evaluate the psychosocial impact of biological treatment outcomes in patients with moderate-to-severe plaque psoriasis in the UK: interim results
Anthony Bewley, Mehbub Shafi, Patricia Gorecki, Manoharan Andiappan, C. Elise Kleyn, Hamish J.A. Hunter and Kave Shams
16:35 – 16:45 PS09 Fordyce spots as a genital manifestation of body dysmorphic disorder in men: cases from a psychodermatology clinic
Alia Ahmed
16:45 – 17:00 PS10 (P37)
Correlation of Psoriasis Disability Index and Psoriasis Area and Severity Index
Ahmad Khalid Aalemi and Abdul Ghafar Hamdard
THURSDAY 7TH JULY
Date: Thursday 7th July
Time: 08:30 – 12:15
Room: Lomond
Chair: Dr Richard Warren & Dr Iqra Ashraf
PROGRAMME
08:30 RF01: THESIS AWARD winner
Development and clinical application of gene therapy for recessive dystrophic epidermolysis bullosa
Dr Su Lwin
08:45 RF02: Hospitalization from COVID-19 is most frequently
observed in patients with atopic dermatitis treated with systemic corticosteroids, and in particular when systemic corticosteroids are used in combination with another immunomodulatory treatment: lessons from the global SECURE-AD registry
Conor Broderick, Annelie H. Musters, David Prieto-Merino, Bernd Arents, Tim Burton, Angela L. Bosma, Ching C. Chi, Godfrey Fletcher, Aaron M. Drucker, Kenji Kabashima, Dmitri Wall, Alan D. Irvine, Phyllis Spuls and Carsten Flohr
09:00 PR01: Psychodermatology: Lessons from the last 20 years
Prof Tony Bewley
09:20 RF03: Risk factors for paradoxical eczema in patients with
psoriasis on biologics: a nested case–control study
Ali Al-Janabi, Amy Foulkes, Christopher Griffiths, Catherine Smith, Nick Reynolds, Brian Kirby and Richard Warren
09:35 RF04: Galea vs. periosteum: impact of excision depth on
outcomes for cutaneous squamous cell carcinoma of the scalp
Christopher Felix Brewer, Reema Chawla and Animesh J.K. Patel
09:50 Break
10:45 RF05: Checkpoint inhibitor associated bullous cutaneous
adverse immune-related events: a multicentre observational study
Anusuya Kawsar, Charlotte Edwards, Catherine A. Harwood, Rubeta Matin, Paul Lorigan, Chris Harland, Pooja Patel, Richard Heywood, Aakrati Gupta, Jasmine Mann, Kara Heelan, James Larkin and Louise Fearfield
11:00 PR02: Clinical and Research Snippets from a Career in
Dermatology
Prof Shernaz Walton
11:20 RF06: BSID Best Paper Immunoglobulin E is a potential driver of itch in dystrophic epidermolysis bullosa pruriginosa through autoimmune inflammation
Marieta Papanikolaou
11:35 PR03: The life cycle of skin cancer stem cells
Prof Girish Patel
11:55 PR04: Genetic, Biological, and Structural Differences in Skin
of Colour
Prof Susan Taylor
13:15 – 13:35 Inv06 Dr Carolyn Charman – Teledermatology advances in 2022; translating technology into transformation and treatment
13:35 – 13:55 Inv07 Dr Jonathan Bowling – Top tips Dermoscopy
13:55 – 14:15 Inv08 Dr John Ingram – Hidradenitis suppurativa (HS): running to catch up
14:15 – 14:45 PA Dr Mabs Chowdhury – President’s Address
14:45 – 15:30 RO Prof Ruth Murphy – Rook Oration – The Role of a Dermatologist
Date: Thursday 7th July
Time: 09:00-12:30
Room: Alsh 1 & 2
Chair: Anita Takwale, Nekma Meah
PROGRAMME
09:00 – 09:10 BH01 Methotrexate monotherapy for alopecia universalis: a successful treatment not to be overlooked
Sophie Rolls
09:10 – 09:20 BH02 (P25) Assessing the clinicophenotypic characteristics and metabolic changes in males with early-onset androgenetic alopecia and altered hormonal profile: a comparative cross-sectional study
Vinay Keshavamurthy, Rajsmita Bhattacharjee, Anuradha Bishnoi, Akanksh Kaushik, Naresh Sachdeva, Arnab Pal, Tarun Narang and Sunil Dogra
09:20 – 09:30 BH03 Assessing triage and screening of pigmented nail lesions via referral form
Orla McFeely, Aoibheann Flynn and Fergal Moloney
09:30 – 10:00 BHGL1 Nail SCC
Dr David de Berker
10:00 – 10:50 Break Exhibition Hall
10:50 – 11:00 BH04 Global Guidelines in Dermatology Mapping Project (GUIDEMAP): a systematic review and critical appraisal of alopecia areata clinical practice guidelines
Leila Asfour, Marianne De Brito, Ali Al-Janabi, William Haw, Carsten Flohr and Zenas Yiu
11:00 – 11:10 BH05 Survey on nail technicians’ knowledge about nails and related skin conditions
Siwaporn Hiranput, Lucy Smith and Paul Devakar Yesudian
11:10 – 11:20 BH06 Clinical trial of combination therapy with oral hydroxychloroquine and topical tacrolimus versus oral finasteride and topical tacrolimus in frontal fibrosing alopecia
Mohamad Goldust
11:20 – 11:30 BH07 (P100) Efficacy of current treatments under study in patients with alopecia areata
Markqayne Ray, Maureen Neary, Bach-Khoa Vu, Harriet Tuson, Noor-E Zannat, Ernest Law, Karolina Wosik, Debanjali Mitra and Sharada Harricharan
11:30 – 12:00 BHGL2 Paediatric hair loss
Prof Bianca Maria Piraccini (Virtual)
Date: Thursday 7th July
Time: 08:30-13:30
Room: M1
Chairs:
Lea Solomon and Tim Clayton
Tess McPherson and Susannah Baron
PROGRAMME
08:30 PA01: More than meets the eye: a case of encephalocraniocutaneous lipomatosis
Catriona Gallagher, Norah McGrath, Irene Timoney and Fiona Browne
08:40 PA02 (P28) Prediction of FLG genotype using human and computer-aided phenotype extraction with random forest machine learning
Bjorn R. Thomas, Lloyd Steele, Reiko J. Tanaka and Edel A. O’Toole
08:50 PA03 Real-world effectiveness and safety of dupilumab in managing children and adolescents with moderate-to-severe atopic dermatitis
Claire Marshall, Zoe Littlewood, Nichola Herety, Calvin Heal, Jennifer Sharif and Tim Clayton
09:00 PA04 Monitoring mental health in children and young people attending dermatology clinics
Mina Almasi-Nasrabadi, Satwinderjit Shinhmar, Susannah Baron, Carsten Flohr, Tess Mcpherson, Emma Howard, Sophie Bennett, Isobel Heyman, Rukshana Ali and Jane Ravenscroft
09:10 PA05 (P92) Patterns of long-term oral antibiotic use in people with acne vulgaris in UK primary care
Ketaki Bhate, Kathryn Mansfield, Sarah-Jo Sinnott, David J. Margolis, Elizabeth Adesanya, Nick Francis, Clemence Leyrat, Susan Hopkins, Richard Stabler, Laura Shallcross, Rohini Mathur and Sinéad Langan
09:20 PA06 Enteral nutrition in the management of refractory orofacial Crohn disease
Caroline McCarthy, Daniel Finn, Bijaya P. Rajlawat and Paul D. Yesudian
09:30 PAGL1 Guest Lecture: Dermatology meets Immunology
Lucy Cliffe (Nottingham)
10:00 Break Exhibition Hall
10:45 PAGL2 Guest Lecture: Practical approach to common paediatric infections
Rachael Morris-Jones (London)
11:10 PAGL3 Guest Lecture: Antibiotics use in Dermatology
Steve Welch
11:35 PA07 A case of ‘vanishing’ skin and twin
Rupali Patel, Sunita Odedra and Annette Loffeld
11:45 PA08 Survey of caregiver satisfaction with remote versus face-to-face consultations in a tertiary paediatric dermatology clinic during the COVID-19 pandemic
Hazel Rooney, Paula E. Beattie, Catherine Jury, Diana Watson and Gordon Hale
11:55 PA09 Clinical outcomes for paediatric cutaneous lymphoma in a tertiary centre
Veronica Melchionda, Eleni Ieremia, Rubeta Matin and Tess McPherson
12:05 PA10 Paediatric melanoma series: are you kidding me?
Elena Ailenei, Sana Sankey, Konstantinos Apostolou, Kamal Bysaria, Sarah Thompson, Aswath Kumar, Vivek Mudaliar, Jane Walker, Lamis Sharaf, Alvin Wong and Manju Paul
12:15 – 13:30 Executive Committee – In M2
Date: Thursday 7th July
Time: 08:30-12:15
Room: Boisdale 1 & 2
Chair: First session: Prof Sally Ibbotson & Dr Vicky McGuire
Second Session: Dr Sophie Weatherhead & Dr Adam Fityan
PROGRAMME
08:30 – 08:50 AGM – (In the Carron 1 & 2)
08:50 – 09:00 PD01 The VOICE registry: a vitiligo database – our first year
Libin Mathew, Magnus Lynch and John Ferguson
09:00 – 09:15 PD02 Oral psoralen + ultraviolet A therapy (PUVA) in the management of hand eczema: real-world data from a specialist centre
Fiona Campbell, Rachel Montgomery and Victoria Goulden
09:15 – 09:30 PD03 Photodermatology training experiences of speciality trainees in the UK
Amaani Hussain, Parastoo Babakinejad, Sally Ibbotson and Sophie Weatherhead
09:30 – 09:45 PD04 Optimizing the risk stratification of liver disease in patients with erythropoietic protoporphyria
Oliver Tavabie, Hiva Fassihi, Adam Fityan, Nisha Arujuna, Harsha Naik, John Ferguson, Varuna Aluvihare and Robert Sarkany
09:45 – 10:15 PDGL1
Guest Lecture: What’s new in photoprotection
Professor Yolanda Gilaberte
10:15 – 10:45 Break Exhibition Hall
10:45 – 11:15 PDGL2 Guest Lecture: Update on porphyria emerging therapies including EPP
Professor Jean-Charles Deybach
11:15 – 11:30 PD05 A new methodology to estimate objectively ultraviolet exposure to the face over a prolonged period: results from its use in patients with xeroderma pigmentosum and in healthy subjects
Robert Sarkany, Martha Canfield, Myfanwy Morgan, Lesley Foster, Kate Johnstone, Kirby Sainsbury, Vera Araujo-Soares, Hans Christian Wulf, John Weinman, Jessica Walburn and Sam Norton
11:30 – 11:45 PD06 An evolving engagement programme for patients with photodermatoses
Marese O’Reilly, Stephanie Logan, Susan Yule, Ewan Eadie and Sally Ibbotson
11:45 – 11:55 PD07 Phototherapy for atopic eczema: a survey of UK and European practice
Mia Steyn, Soudeh Mashayekhi, Annelie Musters, Angela Bosma, Louise Gerbens, Mette Deleuran, Sebastien Barbarot, Laurent Meunier, Phyllis Spuls, Robert Dawe, Sally Ibbotson, John Ferguson and Carsten Flohr
11:55 – 12:05 PD08 Optimization of narrowband ultraviolet B for psoriasis using a precision-medicine approach: PHOTO-OPP study (PHOTOtherapy Optimisation Protocol in Psoriasis)
Alison Havelin, Fedor Schmarov, Paolo Zuliani, Nick Reynolds and Sophie Weatherhead
12:05 – 12:15 PD09 Family ties: erythropoietic protoporphyria
Sanaa Butt, Veronica Haughey, Marese O’Reilly, Nicola Traynor, Vicky McGuire and Robert Dawe
Chairs Piu Banerjee and Rubeta Matin
16:00 Dr Roxana Daneshjou
‘Towards augmented intelligence in dermatology’
16:20 Prof Veronica Rotemberg
‘The promise of imaging standards in improving AI for dermatology’
16:40 Dr Rubeta Matin
‘AI interventions for skin cancer diagnostics in the UK’
17:00 Prof Emanule Trucco
‘Really usable AI in the clinical pathway in dermatology: where are we?Promises, challenges and lessons learnt (the hard way)’
17:20 Topol fellow -Dr Mathew Alexander
17:25 Topol fellow- Dr Zeeshaan Haasan
Your Content Goes Here
This symposium may be useful for dermatology trainees and CESR trainees looking for management training for their portfolio
Date: Thursday 7th July PROGRAMME 16.00 GIRFT01: The long-term costs of COVID-19 for patients with skin cancer patients: a retrospective single-centre review of multidisciplinary team skin cancer cases and outcomes from 2019 to 2021 16.15 GIRFT02: The influence of the COVID-19 pandemic on Breslow thickness and outpatient malignant melanoma service provision in an Irish Dermatology centre 16.30 GIRFT03: The number needed to treat metric: a further marker of the impact of COVID-19 on malignant melanomas 16.45 GIRFT04: Teleconsultations in paediatric dermatology: a UK-wide clinician survey 17.00 GIRFT05: The use of an online teledermatology platform with patient-submitted history and images for waiting list recovery in dermatology 17:15 GIRFT06: Patient questionnaire-based triage improves outcomes for psoriasis referrals |
HOT TOPICS & PHARMA ZONE
They will be semi-informal set-up taking place in two designated areas within the Exhibition Hall 5 during breaks. These are highlighted as HT1 and HT2 on the exhibition plan.
These talks will not be recorded or available post event.
Tuesday 5th July – morning break
10:30 – 11:00 HT1 Differential diagnosis for herpes simplex – Marian Nicolson
10:30 – 11:00 HT2 British Skin Foundation – Lisa Bickerstaff
Tuesday 5th July – afternoon break
14:30 – 15:00 HT1 Osler on skin – David Gawkrodger
14:30 – 15:00 HT2 BAD Journals – John Ingram, Alexa Shipman, George Millington
Wednesday 6th July – morning break
10:30 – 11:00 HT1 BAD-NRDS-Cancer Workstream Update – Zoe Venables & Birgitta van Bodegraven
10:30 – 11:00 HT2 Who was who in British dermatology history – and were they all white men? – Alexa Shipman, Nick Levell, Paul Yesudian
Wednesday 6th July – afternoon break
15:30 – 16:00 HT1 Review of Lipoedema – Sharie Fetzer
15:30 – 16:00 HT2 BADBIR Real World Data – Christopher Griffiths & Zenas Yiu#
Thursday 7th July – morning break
10:15 – 10:45 HT1 What are your patients seeking from National Eczema Society? – Andrew Proctor
10:15 – 10:45 HT2 ASTAR Real World Data – Carsten Flohr
Tuesday 5th July – Lunchtime break
12:30 – 12:45
HT1 (LEO) Proposed presentation: Demographics and drug survival in patients with psoriasis treated with brodalumab enrolled in the British Association of Dermatologists Biologic and Immunomodulators Interventions Register (BADBIR) up to 1 year – Dr Agustin Martin-Clavijo
12:45 – 13:00
HT1 (Novartis) Establishing a joint dermatology and rheumatology clinic – Dr Eva Domanne, Consultant Dermatologist, Countess of Chester NHS Foundation Trust